BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9691098)

  • 1. Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus.
    Meyer C; Stumvoll M; Nadkarni V; Dostou J; Mitrakou A; Gerich J
    J Clin Invest; 1998 Aug; 102(3):619-24. PubMed ID: 9691098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous insulin replacement in type 2 diabetes reverses excessive hepatic glucose release, but not excessive renal glucose release and impaired free fatty acid clearance.
    Woerle HJ; Popa E; Dostou J; Welle S; Gerich J; Meyer C
    Metabolism; 2002 Nov; 51(11):1494-500. PubMed ID: 12404204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes.
    Meyer C; Woerle HJ; Dostou JM; Welle SL; Gerich JE
    Am J Physiol Endocrinol Metab; 2004 Dec; 287(6):E1049-56. PubMed ID: 15304374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis.
    Nielsen MF; Wise S; Dinneen SF; Schwenk WF; Basu A; Rizza RA
    Diabetes; 1997 Dec; 46(12):2007-16. PubMed ID: 9392488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased renal glucose metabolism in Type 1 diabetes mellitus.
    Meyer C; Tolias A; Platanisiotis D; Stumvoll M; Vlachos L; Mitrakou A
    Diabet Med; 2005 Apr; 22(4):453-9. PubMed ID: 15787672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal compensation for impaired hepatic glucose release during hypoglycemia in type 2 diabetes: further evidence for hepatorenal reciprocity.
    Woerle HJ; Meyer C; Popa EM; Cryer PE; Gerich JE
    Diabetes; 2003 Jun; 52(6):1386-92. PubMed ID: 12765948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in basal glucose metabolism during late pregnancy in the conscious dog.
    Connolly CC; Holste LC; Aglione LN; Neal DW; Lacy DB; Smith MS; Diamond MP; Cherrington AD; Chiasson JL
    Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1166-77. PubMed ID: 11052973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.
    Woerle HJ; Szoke E; Meyer C; Dostou JM; Wittlin SD; Gosmanov NR; Welle SL; Gerich JE
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E67-E77. PubMed ID: 16105859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of physiological hyperinsulinemia on systemic, renal, and hepatic substrate metabolism.
    Meyer C; Dostou J; Nadkarni V; Gerich J
    Am J Physiol; 1998 Dec; 275(6):F915-21. PubMed ID: 9843908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism.
    Consoli A; Nurjhan N; Reilly JJ; Bier DM; Gerich JE
    J Clin Invest; 1990 Dec; 86(6):2038-45. PubMed ID: 2254458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamine and alanine metabolism in NIDDM.
    Stumvoll M; Perriello G; Nurjhan N; Bucci A; Welle S; Jansson PA; Dailey G; Bier D; Jenssen T; Gerich J
    Diabetes; 1996 Jul; 45(7):863-8. PubMed ID: 8666134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of splanchnic and renal substrate supply by insulin in humans.
    Cersosimo E; Garlick P; Ferretti J
    Metabolism; 2000 May; 49(5):676-83. PubMed ID: 10831183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal substrate exchange and gluconeogenesis in normal postabsorptive humans.
    Meyer C; Stumvoll M; Dostou J; Welle S; Haymond M; Gerich J
    Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E428-34. PubMed ID: 11788376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
    Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M
    J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM.
    Consoli A; Nurjhan N; Capani F; Gerich J
    Diabetes; 1989 May; 38(5):550-7. PubMed ID: 2653926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes.
    Boden G; Chen X; Capulong E; Mozzoli M
    Diabetes; 2001 Apr; 50(4):810-6. PubMed ID: 11289046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative importance of liver, kidney, and substrates in epinephrine-induced increased gluconeogenesis in humans.
    Meyer C; Stumvoll M; Welle S; Woerle HJ; Haymond M; Gerich J
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E819-26. PubMed ID: 12959936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fatty acids on glucose production and utilization in man.
    Ferrannini E; Barrett EJ; Bevilacqua S; DeFronzo RA
    J Clin Invest; 1983 Nov; 72(5):1737-47. PubMed ID: 6138367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal glucose handling by the kidney in response to hypoglycemia in type 1 diabetes.
    Cersosimo E; Garlick P; Ferretti J
    Diabetes; 2001 Sep; 50(9):2087-93. PubMed ID: 11522675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.